myasthenia : KMLE 의학 검색 엔진 - 의학사전, 의학용어, 의학약어, 의학논문, 약품/의약품 검색

MeSH(Medical Subject Headings) 맞춤 검색 (http://www.nlm.nih.gov) 결과 : 3 페이지: 1

Myasthenia Gravis - 새창 A disorder of neuromuscular transmission characterized by weakness of cranial and skeletal muscles. Autoantibodies directed against acetylcholine receptors damage the motor endplate portion of the NEUROMUSCULAR JUNCTION, impairing the transmission of impulses to skeletal muscles. Clinical manifestations may include diplopia, ptosis, and weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles. THYMOMA is commonly associated with this condition. (Adams et al., Principles of Neurology, 6th ed, p1459)
Synonyms : Myasthenia Gravis, Generalized, Myasthenia Gravis, Ocular, Generalized Myasthenia Gravis, Ocular Myasthenia Gravis
Myasthenia Gravis, Autoimmune, Experimental - 새창 Any autoimmune animal disease model used in the study of MYASTHENIA GRAVIS. Injection with purified neuromuscular junction acetylcholine receptor (AChR) (see RECEPTORS, CHOLINERGIC) components results in a myasthenic syndrome that has acute and chronic phases. The motor endplate pathology, loss of acetylcholine receptors, presence of circulating anti-AChR antibodies, and electrophysiologic changes make this condition virtually identical to human myasthenia gravis. Passive transfer of AChR antibodies or lymphocytes from afflicted animals to normals induces passive transfer experimental autoimmune myasthenia gravis. (From Joynt, Clinical Neurology, 1997, Ch 54, p3)
Synonyms : Autoimmune Experimental Myasthenia Gravis, Experimental Autoimmune Myasthenia Gravis, Passive Transfer, Experimental Myasthenia, Experimental Myasthenia Gravis, Myasthenia Gravis, Autoimmune Experimental, Experimental Myasthenias, Myasthenia, Experimental
Myasthenia Gravis, Neonatal - 새창 A disorder of neuromuscular transmission that occurs in a minority of newborns born to women with myasthenia gravis. Clinical features are usually present at birth or develop in the first 3 days of life and consist of hypotonia and impaired respiratory, suck, and swallowing abilities. This condition is associated with the passive transfer of acetylcholine receptor antibodies through the placenta. In the majority of infants the myasthenic weakness resolves (i.e., transient neonatal myasthenia gravis) although this disorder may rarely continue beyond the neonatal period (i.e., persistent neonatal myasthenia gravis). (From Menkes, Textbook of Child Neurology, 5th ed, p823; Neurology 1997 Jan;48(1):50-4)
Synonyms : Myasthenia Gravis, Neonatal, Persistent, Myasthenia Gravis, Neonatal, Transient, Myasthenia Gravis, Persistent, Neonatal, Myasthenia Gravis, Transient, Neonatal, Neonatal Myasthenia Gravis, Persistent, Neonatal Myasthenia Gravis, Transient